文献速递乳腺MR

基于合成MRI采集的影像组学模型预测三阴性乳腺癌新辅助全身治疗反应

A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer.
PubMed 文献 · Radiol Imaging Cancer · 2023-01-01

前瞻性研究纳入181例I-III期三阴性乳腺癌女性,在基线和NAST四周期后采集SyMRI序列生成T1、T2、PD图,提取影像组学特征。中期治疗图的多变量模型预测pCR的AUC在训练组高达0.78、测试组0.72,优于基线图模型。

要点

  • NAST四周期后的SyMRI定量图影像组学特征有助于识别早期治疗反应者。
  • 中期治疗图多变量模型预测pCR的AUC训练组高达0.78、测试组0.72。
  • 单变量分析中15个T1、10个T2、12个PD中期特征预测pCR的AUC均大于0.70。

核心结论

  • 中期治疗时采集的SyMRI影像组学特征可能有助于识别TNBC的早期NAST反应者。

研究设计与样本

  • 前瞻性研究纳入181例I-III期TNBC女性,基线及NAST四周期后行SyMRI序列生成T1、T2、PD图,以手术病理pCR状态为参考标准。

诊断标准与关键数值

  • 训练组119例(中位年龄52岁,范围26-77岁),独立测试组62例(中位年龄48岁,范围23-74岁)。单变量分析中期治疗15个T1、10个T2、12个PD影像组学特征预测pCR的AUC均大于0.70。多变量模型中期图AUC训练组高达0.78、测试组0.72。

临床应用与阅片要点

  • 作者认为中期治疗SyMRI影像组学特征可能有助于识别TNBC的早期NAST反应者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To determine if a radiomics model based on quantitative maps acquired with synthetic MRI (SyMRI) is useful for predicting neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Materials and Methods In this prospective study, 181 women diagnosed with stage I-III TNBC were scanned with a SyMRI sequence at baseline and at midtreatment (after four cycles of NAST), producing T1, T2, and proton density (PD) maps. Histopathologic analysis at surgery was used to determine pathologic complete response (pCR) or non-pCR status. From three-dimensional tumor contours drawn on the three maps, 310 histogram and textural features were extracted, resulting in 930 features per scan. Radiomic features were compared between pCR and non-pCR groups by using Wilcoxon rank sum test. To build a multivariable predictive model, logistic regression with elastic net regularization and cross-validation was performed for texture feature selection using 119 participants (median age, 52 years [range, 26-77 years]). An independent testing cohort of 62 participants (median age, 48 years [range, 23-74 years]) was used to evaluate and compare the models by area under the receiver operating characteristic curve (AUC). Results Univariable analysis identified 15 T1, 10 T2, and 12 PD radiomic features at midtreatment that predicted pCR with an AUC greater than 0.70 in both the training and testing cohorts. Multivariable radiomics models of maps acquired at midtreatment demonstrated superior performance over those acquired at baseline, achieving AUCs as high as 0.78 and 0.72 in the training and testing cohorts, respectively. Conclusion SyMRI-based radiomic features acquired at midtreatment are potentially useful for identifying early NAST responders in TNBC. Keywords: MR Imaging, Breast, Outcomes Analysis ClinicalTrials.gov registration no. NCT02276443 Supplemental material is available for this article. © RSNA, 2023 See also the commentary by Houser and Rapelyea in this issue.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Hwang KP, Elshafeey NA, Kotrotsou A, et al. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer. Radiol Imaging Cancer. 2023. PMID: 37505106. doi:10.1148/rycan.230009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。